🇺🇸 FDA
Pipeline program

IONIS FXI-LRx

ION 957943-CS1

Phase 1 small_molecule completed

Quick answer

IONIS FXI-LRx for Healthy Participants is a Phase 1 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
IONIS PHARMACEUTICALS INC
Indication
Healthy Participants
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials